BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37355734)

  • 21. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
    Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
    Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders.
    Hyman DM; Diamond EL; Vibat CR; Hassaine L; Poole JC; Patel M; Holley VR; Cabrilo G; Lu TT; Arcila ME; Chung YR; Rampal R; Lacouture ME; Rosen N; Meric-Bernstam F; Baselga J; Kurzrock R; Erlander MG; Janku F; Abdel-Wahab O
    Cancer Discov; 2015 Jan; 5(1):64-71. PubMed ID: 25324352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of FLT3 in haematopoietic malignancies.
    Stirewalt DL; Radich JP
    Nat Rev Cancer; 2003 Sep; 3(9):650-65. PubMed ID: 12951584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. qPCR in gastrointestinal stromal tumors: Evaluation of reference genes and expression analysis of KIT and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL.
    Fassunke J; Blum MC; Schildhaus HU; Zapatka M; Brors B; Künstlinger H; Büttner R; Wardelmann E; Merkelbach-Bruse S
    BMC Mol Biol; 2010 Dec; 11():100. PubMed ID: 21171987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of function Cbl-c mutations in solid tumors.
    Daniels SR; Liyasova M; Kales SC; Nau MM; Ryan PE; Green JE; Lipkowitz S
    PLoS One; 2019; 14(7):e0219143. PubMed ID: 31260484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Go RS; Jacobsen E; Baiocchi R; Buhtoiarov I; Butler EB; Campbell PK; Coulter DW; Diamond E; Flagg A; Goodman AM; Goyal G; Gratzinger D; Hendrie PC; Higman M; Hogarty MD; Janku F; Karmali R; Morgan D; Raldow AC; Stefanovic A; Tantravahi SK; Walkovich K; Zhang L; Bergman MA; Darlow SD
    J Natl Compr Canc Netw; 2021 Nov; 19(11):1277-1303. PubMed ID: 34781268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
    Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
    BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Internal tandem duplication in the juxtamembrane domain of the Flt3 gene found in leukemias].
    Yokota S; Kiyoi H
    Rinsho Ketsueki; 1998 Feb; 39(2):83-5. PubMed ID: 9545804
    [No Abstract]   [Full Text] [Related]  

  • 29. ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.
    Lucas CG; Gilani A; Solomon DA; Liang X; Maher OM; Chamyan G; Kleinschmidt-Demasters BK; Perry A
    Acta Neuropathol; 2019 Aug; 138(2):335-337. PubMed ID: 31119374
    [No Abstract]   [Full Text] [Related]  

  • 30. How I Diagnose Rosai-Dorfman Disease.
    Ravindran A; Rech KL
    Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trametinib in the treatment of multiple malignancies harboring MEK1 mutations.
    Lian T; Li C; Wang H
    Cancer Treat Rev; 2019 Dec; 81():101907. PubMed ID: 31715422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
    Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
    J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activating mutations in receptor tyrosine kinases with relevance for treatment of gastrointestinal stromal tumors].
    Wardelmann E; Merkelbach-Bruse S; Büttner R; Schildhaus HU
    Verh Dtsch Ges Pathol; 2007; 91():165-8. PubMed ID: 18314611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malfunctions within the Cbl interactome uncouple receptor tyrosine kinases from destructive transport.
    Dikic I; Schmidt MHH
    Eur J Cell Biol; 2007 Sep; 86(9):505-12. PubMed ID: 17553592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines.
    Yokota S; Kiyoi H; Nakao M; Iwai T; Misawa S; Okuda T; Sonoda Y; Abe T; Kahsima K; Matsuo Y; Naoe T
    Leukemia; 1997 Oct; 11(10):1605-9. PubMed ID: 9324277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling CSF-1 receptor deficiency diseases - how close are we?
    Chitu V; Gökhan Ş; Stanley ER
    FEBS J; 2022 Sep; 289(17):5049-5073. PubMed ID: 34145972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homozygosity for a novel large deletion in SLC29A3 in a patient with H syndrome.
    Shankar SG; Rangarajan S; Priyadarshini A; Swaminathan A; Sundaram M
    Pediatr Dermatol; 2020 Mar; 37(2):333-336. PubMed ID: 31867772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease.
    Abeykoon JP; Lasho TL; Dasari S; Rech KL; Ranatunga WK; Manske MK; Tischer A; Ravindran A; Young JR; Tobin WO; Flanagan EP; Nowakowski KE; Ruan GJ; Shah MV; Bennani NN; Vassallo R; Ryu JH; Koster MJ; Davidge-Pitts CJ; Patnaik MM; Wu X; Witzig TE; Goyal G; Go RS;
    Am J Hematol; 2022 Mar; 97(3):293-302. PubMed ID: 34978715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical Histiocytic Lesion Preceding a Peripheral T-Cell Lymphoma Involving the Skin Exhibiting the Same Molecular Alterations.
    Machan S; Córdoba R; Carvajal N; Requena L; Piris MÁ; Facchetti F; Rodríguez-Pinilla SM
    Am J Dermatopathol; 2019 Feb; 41(2):148-154. PubMed ID: 30085957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative regulation of EphA2 receptor by Cbl.
    Wang Yj; Ota S; Kataoka H; Kanamori M; Li Zy; Band H; Tanaka M; Sugimura H
    Biochem Biophys Res Commun; 2002 Aug; 296(1):214-20. PubMed ID: 12147253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.